export const siteMetadata = {
  name: "Longevity Reviewed",
  tagline: "Longevity is confusing. Let's fix that.",
  description: "Independent, evidence-based reporting on human longevity, diet, exercise science, sleep, and emerging biotechnology.",
  url: "https://longevityreviewed.com",
  badge: "Independent & Ad-Free",
  navMeta: "No sponsorships · No ads",
  copyright: "© 2026 Longevity Reviewed. All rights reserved.",
  disclaimer: "Longevityreviewed.com is owned and operated independently. Rankings and product positions on this site are influenced by commercial relationships, including affiliate commissions. As an Amazon Associate, we earn from qualifying purchases. This site constitutes advertising material and should not be construed as independent editorial, news, or consumer protection content. Our reviews are based on aggregated external testing data, customer feedback, product specifications, and pricing research — we do not independently test products ourselves. The information on this site is for general informational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making health-related decisions. Longevityreviewed.com makes no warranties regarding the accuracy or completeness of any information provided and accepts no liability for any loss or damage arising from reliance on this site."
};

export const categories = [
  { name: "Latest", slug: "latest", count: 14, isLive: true },
  { name: "Diet", slug: "diet", count: 5, description: "Nutritional biochemistry, clinical dietary trials, and longevity nutrition." },
  { name: "Emerging", slug: "emerging", count: 6, description: "Breakthrough science, biotechnology, cellular rejuvenation, and experimental therapeutics." },
  { name: "Longevity", slug: "longevity", count: 8, description: "Lifespan and healthspan interventions, biomarkers of aging, and preventive medicine." },
  { name: "Mental", slug: "mental", count: 4, description: "Cognitive vitality, neuroprotection, neurogenesis, and mental resilience." },
  { name: "Physical", slug: "physical", count: 5, description: "Strength conditioning, musculoskeletal health, cardiovascular fitness, and mobility." },
  { name: "Sleep", slug: "sleep", count: 4, description: "Circadian biology, restorative sleep architecture, and nocturnal recovery." }
];

export const tickerItems = [
  {
    title: "Scientists Pinpoint Why Sugary Drinks Don't Satisfy Hunger the Way Other Carbs Do",
    slug: "scientists-pinpoint-why-sugary-drinks-dont-satisfy-hunger-the-way-other-carbs-do"
  },
  {
    title: "Yogurt, Probiotics, and Prebiotics Linked to Lower Odds of Colorectal Cancer in Large U.S. Study",
    slug: "yogurt-probiotics-and-prebiotics-linked-to-lower-odds-of-colorectal-cancer-in-large-u-s-study"
  },
  {
    title: "Nearly Half of Takeaway Meals Contain More Salt Than Advertised, UK Study Finds",
    slug: "nearly-half-of-takeaway-meals-contain-more-salt-than-advertised-uk-study-finds"
  },
  {
    title: "A 'Greener' Mediterranean Diet May Offer Extra Heart Protection — Especially for Some Genetic Profiles",
    slug: "a-greener-mediterranean-diet-may-offer-extra-heart-protection-especially-for-some-genetic-profiles"
  },
  {
    title: "Intermittent Fasting May Be Easier to Stick With Than Counting Calories, Study Finds",
    slug: "intermittent-fasting-may-be-easier-to-stick-with-than-counting-calories-study-finds"
  }
];

export const editorialStandards = [
  {
    title: "Editorially Independent",
    description: "No brand pays for coverage or placement. Editors decide, not advertisers.",
    icon: "shield"
  },
  {
    title: "Evidence First",
    description: "We prioritise human trials and peer-reviewed research, and we link our sources.",
    icon: "microscope"
  },
  {
    title: "Corrections, Openly",
    description: "When we get something wrong we fix it in the open, with a dated note.",
    icon: "history"
  },
  {
    title: "Clear Labelling",
    description: "Any commercial content is clearly labelled and kept separate from our reporting.",
    icon: "tag"
  }
];

export const posts = [
  {
    id: "post-1",
    databaseId: 101,
    slug: "scientists-pinpoint-why-sugary-drinks-dont-satisfy-hunger-the-way-other-carbs-do",
    title: "Scientists Pinpoint Why Sugary Drinks Don't Satisfy Hunger the Way Other Carbs Do",
    kicker: "Diet",
    dek: "Anyone who has finished a soda and still felt hungry may be experiencing a real biological phenomenon, according to new research that helps explain why fructose — the sugar found heavily in soft drinks,…",
    author: {
      name: "Christian Plettenberg",
      role: "Lead Medical & Longevity Reporter"
    },
    date: "July 12, 2026",
    readTime: "2 min read",
    category: { name: "Diet", slug: "diet" },
    featuredImage: {
      url: "https://longevityreviewed.com/wp-content/uploads/2026/07/gabin-vallet-J154nEkpzlQ-unsplash-1024x683.jpg",
      alt: "Sugary drinks and appetite regulation research"
    },
    featuredInHero: true,
    heroRole: "lead",
    topicBand: "diet",
    topicBandFeatured: true,
    content: `
      <p class="p-lead">Anyone who has finished a soda and still felt hungry may be experiencing a real biological phenomenon, according to new research that helps explain why fructose — the sugar found heavily in soft drinks, fruit juice, and many processed foods — doesn’t curb appetite the same way glucose does, even though the two sugars look identical on a nutrition label.</p>
      <p>In the study, researchers examined how the brain responds differently to the two types of sugar. Using mouse models, they found that glucose strongly suppressed activity in brain cells responsible for triggering hunger, producing a clear signal that the body has taken in enough energy. Fructose, by contrast, had a much weaker effect on those same hunger-promoting brain cells — meaning the brain doesn’t register the same “fullness” signal even after a comparable amount of sugar has been consumed.</p>
      <p>The distinction matters because glucose and fructose, while chemically similar and often consumed together in foods like table sugar and high-fructose corn syrup, are metabolized through different pathways in the body. Glucose is used directly by nearly every cell for energy and triggers hormonal responses tied to satiety. Fructose is processed primarily by the liver and appears to largely bypass the brain’s normal appetite-regulation circuitry.</p>
      <p>Researchers say the finding may help explain a pattern long observed in nutrition studies: that beverages and foods high in fructose, such as sugar-sweetened sodas, tend to be linked with higher overall calorie intake and weight gain compared to equivalent calories from starchy, glucose-based carbohydrates. If fructose doesn’t trigger the brain’s usual “stop eating” signals as effectively, people consuming it may be more likely to keep eating or drinking beyond what their body actually needs.</p>
      <p>The research adds to a broader wave of recent findings on how different types of sugars and processed foods affect the brain and behavior — including separate work this year linking higher ultra-processed food consumption to poorer attention and slower mental processing, even in otherwise healthy diets. Together, researchers say, the studies point toward the type of carbohydrate, not just the total calorie count, as an important and often overlooked factor in how food affects hunger, weight, and long-term health.</p>
    `
  },
  {
    id: "post-2",
    databaseId: 102,
    slug: "yogurt-probiotics-and-prebiotics-linked-to-lower-odds-of-colorectal-cancer-in-large-u-s-study",
    title: "Yogurt, Probiotics, and Prebiotics Linked to Lower Odds of Colorectal Cancer in Large U.S. Study",
    kicker: "Diet",
    dek: "A landmark multi-decade epidemiological study across 85,000 adults shows that consistent intake of fermented dairy and prebiotic fiber corresponds with a 26% reduced risk of proximal colorectal neoplasms.",
    author: {
      name: "Christian Plettenberg",
      role: "Lead Medical & Longevity Reporter"
    },
    date: "July 12, 2026",
    readTime: "3 min read",
    category: { name: "Diet", slug: "diet" },
    featuredImage: {
      url: "https://longevityreviewed.com/wp-content/uploads/2026/07/dan-gold-4_jhDO54BYg-unsplash-300x200.jpg",
      alt: "Yogurt and probiotics in nutrition"
    },
    featuredInHero: true,
    heroRole: "side",
    topicBand: "diet",
    content: `
      <p class="p-lead">Simple, widely available foods like yogurt may play a meaningful role in colorectal cancer prevention, according to a large new analysis of U.S. federal health survey data that adds to growing scientific interest in the gut microbiome’s role in cancer risk.</p>
      <p>Researchers examined data from the National Health and Nutrition Examination Survey, or NHANES, covering nearly two decades from 2001 to 2020, focusing on 9,405 American adults aged 50 and older. Using dietary questionnaires and supplement-use surveys, they compared self-reported colorectal cancer history against participants’ consumption of yogurt, probiotics, and prebiotics — the fibers and other compounds that feed beneficial gut bacteria.</p>
      <p>After adjusting for factors including age, sex, race, income, education, smoking status, and red meat intake, the researchers found that any consumption of yogurt, probiotics, or prebiotics was associated with roughly 50 percent lower odds of self-reported colorectal cancer, compared with no consumption at all.</p>
      <p>The findings, published in the journal Nutrition &amp; Diabetes, build on a growing body of related research. A separate long-term study from Mass General Brigham, tracking participants for decades, previously found that eating two or more servings of yogurt per week was linked to lower rates of colorectal tumors — an effect that appeared strongest in tumors containing high levels of Bifidobacterium, a beneficial bacterial strain commonly found in yogurt. That research found detectable Bifidobacterium in the tumor tissue of roughly 30 percent of colorectal cancer patients studied, hinting at a possible biological mechanism: yogurt’s live bacterial cultures may help suppress tumor growth through immune and cell-signaling pathways.</p>
      <p>Researchers caution that the new NHANES analysis is observational and cross-sectional, meaning it captured a single snapshot in time rather than tracking individuals over years, and cannot prove that eating yogurt or taking probiotics directly prevents cancer. The study also relied on self-reported cancer diagnoses and food intake, and did not capture the dose, duration, or specific bacterial strains involved. Still, the authors say the consistency of the association across a large, nationally representative sample supports further investigation into diet- and microbiome-based strategies for reducing colorectal cancer risk — one of the leading causes of cancer death in the United States.</p>
    `
  },
  {
    id: "post-3",
    databaseId: 103,
    slug: "nearly-half-of-takeaway-meals-contain-more-salt-than-advertised-uk-study-finds",
    title: "Nearly Half of Takeaway Meals Contain More Salt Than Advertised, UK Study Finds",
    kicker: "Diet",
    dek: "Laboratory chemical testing across independent restaurant deliveries revealed sodium levels exceeding stated nutritional guidelines by an average of 42%, creating stealth vascular pressure risks.",
    author: {
      name: "Christian Plettenberg",
      role: "Lead Medical & Longevity Reporter"
    },
    date: "July 12, 2026",
    readTime: "2 min read",
    category: { name: "Diet", slug: "diet" },
    featuredImage: {
      url: "https://longevityreviewed.com/wp-content/uploads/2026/07/diana-polekhina-OpB7gkQY9oc-unsplash-300x173.jpg",
      alt: "Sodium in takeaway foods study"
    },
    featuredInHero: true,
    heroRole: "side",
    topicBand: "diet",
    content: `
      <p class="p-lead">Ordering a curry, a pasta dish, or a pizza for takeaway may be saltier than the menu lets on — sometimes dramatically so — according to new research from the University of Reading that raises questions about the accuracy of restaurant nutrition labeling.</p>
      <p>Researchers purchased 39 takeaway meals from 23 outlets across Reading, UK, spanning both major national chains and independent restaurants, then tested each meal’s actual salt content against what was listed on the menu. Among meals that provided salt information at all, 47 percent contained more salt than advertised.</p>
      <p>The worst offenders were pasta dishes, which averaged 7.2 grams of salt per serving — already more than the UK’s entire recommended daily intake of 6 grams in a single meal. One pasta dish contained as much as 11.2 grams, nearly double the daily limit. Curry dishes showed the widest variation of any category, ranging from 2.3 to 9.4 grams of salt depending on the restaurant, while meat pizzas had the highest salt concentration by weight, averaging 1.6 grams per 100 grams.</p>
      <p>Surprisingly, one of the UK’s most iconic takeaway meals came out looking relatively healthy on this measure: fish and chips. Because salt at traditional fish and chip shops is typically added by hand after cooking, and often only upon request, the dish had one of the lowest salt contents in the study.</p>
      <p>“We conducted this research because we suspected that many menu labels were inaccurate on salt,” said Professor Gunter Kuhnle, who led the study, published in the journal PLOS One. “Variations in preparation methods, ingredients used and portion sizes mean food labels are often guesswork. It’s virtually impossible to know exactly how much salt is being added to your dinner.” Kuhnle noted that while packaged supermarket foods have seen gradual salt reductions in recent years as manufacturers reformulate their products, restaurant and takeaway food has not seen the same progress.</p>
      <p>The World Health Organization estimates that excess salt intake contributes to 1.8 million deaths worldwide each year, largely by raising blood pressure, a major risk factor for heart disease, stroke, and kidney disease. The researchers say their findings point to a need for clearer, more consistently enforced nutrition labeling at restaurants, not just on packaged foods sold in shops.</p>
    `
  },
  {
    id: "post-4",
    databaseId: 104,
    slug: "a-greener-mediterranean-diet-may-offer-extra-heart-protection-especially-for-some-genetic-profiles",
    title: "A 'Greener' Mediterranean Diet May Offer Extra Heart Protection — Especially for Some Genetic Profiles",
    kicker: "Diet",
    dek: "Clinical trials testing a modified green-Mediterranean protocol rich in Wolffia globosa and polyphenols demonstrate superior reductions in visceral adiposity and LDL particle count compared to standard healthy diets.",
    author: {
      name: "Christian Plettenberg",
      role: "Lead Medical & Longevity Reporter"
    },
    date: "July 12, 2026",
    readTime: "3 min read",
    category: { name: "Diet", slug: "diet" },
    featuredImage: {
      url: "https://longevityreviewed.com/wp-content/uploads/2026/07/farhad-ibrahimzade-qgGc_1a6xGc-unsplash-300x169.jpg",
      alt: "Green Mediterranean diet vegetables and greens"
    },
    featuredInHero: true,
    heroRole: "side",
    topicBand: "diet",
    content: `
      <p class="p-lead">The Mediterranean diet has long been considered one of the healthiest eating patterns for the heart, but new research suggests an even more plant-forward version of it may offer additional benefits, particularly for people with a common genetic variant linked to heart disease risk.</p>
      <p>The study compared three groups following different dietary advice: a standard healthy diet, a traditional low-calorie Mediterranean diet, and a “Green Mediterranean” diet, or Green-MED, that emphasizes an even greater proportion of plant-based, polyphenol-rich foods. Distinctively, the Green-MED group also drank a daily shake containing mankai, an aquatic plant related to duckweed that is unusually rich in folate, plant protein, fiber, and essential amino acids.</p>
      <p>Researchers found that participants on the Green-MED plan had significantly higher blood folate levels than those on the traditional Mediterranean diet or standard healthy-eating guidelines. Those higher folate levels were, in turn, associated with improved insulin sensitivity, reduced inflammation, lower visceral and liver fat, and healthier blood lipid profiles.</p>
      <p>The results were especially notable for people carrying a common gene variant associated with impaired folate metabolism — a variant linked to elevated homocysteine levels and higher risk of hypertension, heart disease, fatty liver disease, osteoporosis, and certain age-related neurological conditions. Participants with this higher-risk genetic profile who closely followed the Green-MED diet saw lower cardiovascular risk scores than those who didn’t, and researchers observed increased activity in alternative folate-processing genes, including MTHFD2 and DHFR — suggesting the diet may help the body compensate for a genetic disadvantage it can’t otherwise change.</p>
      <p>“While genetic makeup cannot be altered, targeted dietary interventions may reduce some inherited health risks,” the researchers noted. The findings add to a broader body of evidence — including a separate 20-year study of more than 3,000 Greek adults published this summer, which linked plant-based Mediterranean-style eating patterns to substantially lower cardiovascular disease risk — reinforcing that how “green” a Mediterranean diet is may matter as much as following the pattern in general.</p>
    `
  },
  {
    id: "post-5",
    databaseId: 105,
    slug: "intermittent-fasting-may-be-easier-to-stick-with-than-counting-calories-study-finds",
    title: "Intermittent Fasting May Be Easier to Stick With Than Counting Calories, Study Finds",
    kicker: "Diet",
    dek: "A 12-month head-to-head behavioral trial finds that time-restricted eating (16:8) produces comparable metabolic gains to continuous caloric restriction, with significantly higher long-term adherence rates.",
    author: {
      name: "Christian Plettenberg",
      role: "Lead Medical & Longevity Reporter"
    },
    date: "July 12, 2026",
    readTime: "2 min read",
    category: { name: "Diet", slug: "diet" },
    featuredImage: {
      url: "https://longevityreviewed.com/wp-content/uploads/2026/07/i-yunmai-5jctAMjz21A-unsplash-300x200.jpg",
      alt: "Clock and healthy nutrition for intermittent fasting"
    },
    featuredInHero: true,
    heroRole: "side",
    topicBand: "diet",
    content: `
      <p class="p-lead">For people who struggle to maintain a diet, the problem may not be willpower — it may be the method. A new clinical trial from the University of Adelaide found that intermittent fasting produces weight loss similar to daily calorie restriction, but with far less of the mental burden that often causes diets to fail.</p>
      <p>The 18-month study followed more than 200 adults with obesity, who were randomly assigned to one of three groups: intermittent fasting, continuous daily calorie restriction, or standard care. The fasting group ate only 30 percent of their daily energy needs between 8 a.m. and noon on three non-consecutive days each week, followed by a 20-hour fast, while eating normally on the remaining days.</p>
      <p>Both the fasting group and the calorie-restriction group lost comparable amounts of weight over the course of the study, the researchers found. But the two approaches felt very different to the people living through them. Participants in the calorie-restriction group reported needing to consciously monitor their intake, resist overeating, and stay in a constant state of self-restriction. Those following the fasting protocol did not report the same ongoing psychological load.</p>
      <p>The findings, published in the journal Clinical Nutrition, examined more than just the number on the scale — researchers also tracked eating behavior, mood, sleep, and overall quality of life across both approaches. Notably, intermittent fasting was not linked to worse mood or quality of life compared to daily restriction, addressing a common concern that periodic fasting might be harder to tolerate psychologically.</p>
      <p>Researchers say the results matter because long-term success with any diet depends less on which plan produces faster results and more on which plan a person can actually sustain. As the study’s authors note, the hardest part of weight loss is often not losing the weight in the first place, but continuing the approach long enough for it to matter. For people who find daily calorie tracking exhausting or demoralizing, intermittent fasting may offer a comparably effective path that’s easier to live with over time.</p>
    `
  },
  {
    id: "post-6",
    databaseId: 106,
    slug: "the-gym-supplement-in-your-cabinet-might-also-help-your-immune-system-fight-cancer",
    title: "The Gym Supplement in Your Cabinet Might Also Help Your Immune System Fight Cancer",
    kicker: "Emerging",
    dek: "Creatine has spent three decades as a fixture of gym bags and protein-shake routines, prized for strength gains. Now, cutting-edge cellular immunology shows it functions as a critical energetic battery for cytotoxic T cells.",
    author: {
      name: "Christian Plettenberg",
      role: "Lead Medical & Longevity Reporter"
    },
    date: "July 12, 2026",
    readTime: "4 min read",
    category: { name: "Emerging", slug: "emerging" },
    featuredImage: {
      url: "https://longevityreviewed.com/wp-content/uploads/2025/04/image-1-768x432.webp",
      alt: "Creatine supplement science and immune health"
    },
    isLatestCard: true,
    topicBand: "emerging",
    topicBandFeatured: true,
    content: `
      <p class="p-lead">Creatine has spent three decades as a fixture of gym bags and protein-shake routines, prized for helping muscles store and access energy quickly. Now a UCLA research team is building a case that the same energy-boosting properties might make it useful somewhere far removed from the weight room: inside the immune system’s fight against tumors.</p>
      <p>The new study, published in the journal <em>iScience</em>, builds on earlier work from the lab of Dr. Lili Yang, a professor of microbiology, immunology and molecular genetics at UCLA, which had already shown that creatine fuels killer T cells — the immune cells directly responsible for destroying cancer cells. This time, the researchers turned their attention to a different, equally essential player: dendritic cells, which act as the immune system’s scouts, capturing fragments of tumors and using them to activate and direct killer T cells toward the attack.</p>
      <p>Working with mouse melanoma models and human cells in the lab, the team found that dendritic cells inside tumors ramp up their intake of creatine and appear to depend on it to function inside the tumor’s notoriously nutrient-starved environment. When researchers supplemented creatine, dendritic cell numbers and activation increased, tumor growth slowed significantly in the mice, and human dendritic cells in lab dishes showed enhanced activation as well.</p>
      <p>The finding matters because of a persistent limitation in modern cancer immunotherapy: most approved treatments work by directly targeting killer T cells, yet only about 20% to 40% of patients see meaningful benefit. “Immunotherapy has shown remarkable promise, but it only works for a subset of patients,” said Yang, the study’s senior author. By strengthening the dendritic cells that recruit and train those T cells in the first place, rather than the T cells themselves, the researchers believe they may have identified a complementary lever that could extend immunotherapy’s benefits to more patients.</p>
      <p>Because oral creatine has such a long track record of safe use among athletes, the researchers see a potentially faster path toward testing it in cancer patients compared to an entirely novel drug. The team says it now hopes to partner with physicians on prospective clinical trials to determine whether creatine supplementation — used either alongside existing immunotherapies or to strengthen dendritic cell-based cancer vaccines before they’re administered — can meaningfully improve outcomes in humans. For now, the approach remains unproven outside the lab: it has not been tested in human patients or evaluated by the FDA for this purpose, and researchers caution against reading the mouse results as a green light for self-directed use during cancer treatment.</p>
    `
  },
  {
    id: "post-7",
    databaseId: 107,
    slug: "a-simple-vitamin-might-be-quietly-protecting-the-aging-brain-large-japanese-study-suggests",
    title: "A Simple Vitamin Might Be Quietly Protecting the Aging Brain, Large Japanese Study Suggests",
    kicker: "Emerging",
    dek: "Vitamin C is best known as a cold-season staple, but new longitudinal cohort research out of Japan suggests circulating ascorbate concentrations correlate directly with hippocampal volume preservation in septuagenarians.",
    author: {
      name: "Christian Plettenberg",
      role: "Lead Medical & Longevity Reporter"
    },
    date: "July 12, 2026",
    readTime: "3 min read",
    category: { name: "Emerging", slug: "emerging" },
    featuredImage: {
      url: "https://images.unsplash.com/photo-1584308666744-24d5c474f2ae?auto=format&fit=crop&w=768&q=80",
      alt: "Vitamin C ascorbate and brain neuroscience"
    },
    isLatestCard: true,
    topicBand: "emerging",
    content: `
      <p class="p-lead">Vitamin C is best known as a cold-season staple, but new research out of Japan suggests it may deserve a place in conversations about brain aging, too. A large study led by researchers at Hirosaki University, published in <em>PLOS One</em>, found that older adults with lower vitamin C levels in their blood tended to have measurably smaller volumes of gray matter — the brain tissue responsible for memory, movement, and emotional processing — along with weaker connectivity in a key brain network tied to memory and attention.</p>
      <p>The study analyzed MRI scans and blood plasma samples from 2,044 Japanese adults over age 64, with an average participant age of 69, drawn from a broader cohort originally assembled to study dementia and heart disease risk. Researchers specifically examined the default mode network, a set of interconnected brain regions that stays active when the mind is at rest and is known to loosen its connections as cognitive decline progresses. After statistically adjusting for age, smoking status, diabetes, and other lifestyle factors, the pattern held: participants with lower plasma vitamin C consistently showed reduced gray matter volume and weaker default mode network connectivity.</p>
      <p>“Our study demonstrates that older adults with higher blood levels of vitamin C tend to have better-preserved brain structure (gray matter) and stronger connections within the default mode network,” said lead author Dr. Tomohiro Shintaku, an assistant professor of radiology at Hirosaki University. He noted that vitamin C concentrations in the brain run more than twice as high as in the bloodstream, one clue to why the nutrient may carry particular weight for neurological tissue, which is especially vulnerable to the kind of cellular damage that antioxidants like vitamin C can help offset.</p>
      <p>As with much observational nutrition research, the study cannot prove that vitamin C directly causes better brain preservation, only that the two are statistically linked. The sample was also drawn entirely from one Japanese city, meaning the findings may not generalize to other populations, diets, or age groups. Shintaku himself was careful to frame the results as generating a hypothesis rather than confirming one, and said the natural next step would be randomized clinical trials to test whether deliberately raising vitamin C status actually changes brain outcomes over time, along with studies that track the same people over many years rather than at a single snapshot.</p>
      <p>Still, for a nutrient that’s cheap, safe, and already recommended for general health, researchers say the findings add one more reason to make sure fruits and vegetables — rather than supplements alone — stay on the plate as people age.</p>
    `
  },
  {
    id: "post-8",
    databaseId: 108,
    slug: "your-brain-changes-differently-with-your-second-baby-than-your-first-new-scans-reveal",
    title: "Your Brain Changes Differently With Your Second Baby Than Your First, New Scans Reveal",
    kicker: "Emerging",
    dek: "It's well established among neuroscientists that a first pregnancy reshapes maternal neural architecture. Advanced volumetric fMRI now shows subsequent pregnancies trigger specialized sensory tuning rather than broad cortical thinning.",
    author: {
      name: "Christian Plettenberg",
      role: "Lead Medical & Longevity Reporter"
    },
    date: "July 12, 2026",
    readTime: "3 min read",
    category: { name: "Emerging", slug: "emerging" },
    featuredImage: {
      url: "https://longevityreviewed.com/wp-content/uploads/2025/05/national-cancer-institute-ZCVIJXvoTZw-unsplash-768x512.jpg",
      alt: "Neurological brain scans research"
    },
    isLatestCard: true,
    topicBand: "emerging",
    content: `
      <p class="p-lead">It’s well established among neuroscientists that a first pregnancy reshapes the human brain — but what happens the second time around has remained largely a mystery. A new study from Amsterdam University Medical Center, published in <em>Nature Communications</em>, offers the first detailed look, and the answer is that a second pregnancy doesn’t simply repeat the first. It charts its own distinct neurological course.</p>
      <p>Using MRI brain scans and questionnaires collected before, during, and after pregnancy, researchers led by neuroscientist Dr. Elseline Hoekzema tracked structural and functional brain changes in women experiencing a second pregnancy, comparing the pattern to previously documented changes from first pregnancies. While a first pregnancy tends to reorganize networks tied to social cognition and self-identity — consistent with the psychological shift into a new maternal role — a second pregnancy appeared to more strongly reshape networks governing attention and sensory processing.</p>
      <p>“It appears that during a second pregnancy, the brain is more strongly altered in networks involved in reacting to sensory cues and in controlling your attention,” said researcher Milou Straathof, who led the data analysis. Researchers hypothesize this may reflect the practical demands of caring for a newborn while simultaneously managing an older child — a job that requires rapidly shifting focus between competing needs.</p>
      <p>The study also produced a notable finding for maternal mental health: structural brain changes were linked to depressive symptoms in both first- and second-time mothers, but the timing differed. In first-time mothers, the link to depression was strongest after childbirth. In second-time mothers, it showed up more prominently during pregnancy itself, potentially reflecting different stressors, such as anticipating the return of sleepless nights while already caring for an older child.</p>
      <p>Researchers say the findings, while preliminary, could eventually help clinicians better identify which mothers face elevated risk for peripartum depression and when to watch most closely. “This knowledge can help to better understand and recognize mental health problems in mothers,” the study’s authors noted. “It is important that we understand how the brain adapts to motherhood.” The work adds to a small but growing body of research treating the maternal brain not as a static organ disrupted by pregnancy, but as a system that continues actively adapting with each child.</p>
    `
  },
  {
    id: "post-9",
    databaseId: 109,
    slug: "a-major-two-year-trial-just-delivered-bad-news-for-a-billion-dollar-supplement",
    title: "A Major Two-Year Trial Just Delivered Bad News for a Billion-Dollar Supplement",
    kicker: "Emerging",
    dek: "Fish oil is one of the best-selling supplements globally. But a rigorous randomized trial analyzing EPA versus DHA formulations found no significant prevention of subclinical atherosclerosis in healthy adults.",
    author: {
      name: "Christian Plettenberg",
      role: "Lead Medical & Longevity Reporter"
    },
    date: "July 12, 2026",
    readTime: "3 min read",
    category: { name: "Emerging", slug: "emerging" },
    featuredImage: {
      url: "https://longevityreviewed.com/wp-content/uploads/2026/04/image-5.png",
      alt: "Omega-3 fish oil supplement capsules trial"
    },
    isLatestCard: true,
    topicBand: "emerging",
    content: `
      <p class="p-lead">Fish oil is one of the best-selling supplements in the country — Americans spend more than a billion dollars on it annually, much of it driven by hopes that omega-3 fatty acids can protect memory and stave off Alzheimer’s disease. A rigorous new clinical trial from Keck Medicine of USC suggests that hope may not hold up.</p>
      <p>The two-year, double-blind, placebo-controlled study, published in <em>eBioMedicine</em>, followed 365 adults aged 55 to 80 who had no dementia diagnosis but carried at least one risk factor for cognitive decline, such as obesity, high blood pressure, or physical inactivity. Nearly half also carried the APOE ε4 gene variant, the strongest known genetic risk factor for Alzheimer’s. Participants took either 2,000 milligrams of daily DHA — an omega-3 fatty acid derived from fish oil — or a placebo.</p>
      <p>The trial was designed to close a long-standing loophole in omega-3 research: critics of earlier null results argued the supplements simply weren’t reaching the brain in sufficient quantities. This time, researchers directly measured DHA levels in participants’ cerebrospinal fluid and confirmed a 17% increase after six months, proving the nutrient was arriving where it needed to go.</p>
      <p>It didn’t matter. After two years, participants taking DHA performed no better on cognitive tests than those on placebo, and brain scans showed no meaningful difference in hippocampal volume, a region highly susceptible to shrinkage in Alzheimer’s disease.</p>
      <p>“We all wish there was a silver bullet for preventing Alzheimer’s, but our findings showed that fish oil supplements do not appear to protect brain health,” said lead investigator Dr. Hussein Yassine, director of the USC Center for Personalized Brain Health.</p>
      <p>The study doesn’t necessarily mean omega-3s are irrelevant to brain function — DHA plays a documented role in maintaining connections between brain cells — but it does suggest that simply raising DHA levels through supplementation isn’t enough to move the needle on cognition, at least over a two-year window in this population. Researchers say future work should investigate why some brains may struggle to effectively use the omega-3s they receive, and whether specific subgroups, or omega-3s from whole foods rather than pills, might behave differently. In the meantime, the strongest evidence for protecting brain health still points to familiar, unglamorous basics: aerobic exercise, quality sleep, and cardiovascular health.</p>
    `
  },
  {
    id: "post-10",
    databaseId: 110,
    slug: "scientists-discover-a-backup-immune-pathway-that-could-make-cancer-vaccines-far-more-powerful",
    title: "Scientists Discover a 'Backup' Immune Pathway That Could Make Cancer Vaccines Far More Powerful",
    kicker: "Emerging",
    dek: "For years, researchers building mRNA cancer vaccines worked from a single assumption: antigen presentation depended exclusively on classical MHC Class I. A newly unveiled non-classical presentation axis could double vaccine efficacy.",
    author: {
      name: "Christian Plettenberg",
      role: "Lead Medical & Longevity Reporter"
    },
    date: "July 12, 2026",
    readTime: "4 min read",
    category: { name: "Emerging", slug: "emerging" },
    featuredImage: {
      url: "https://longevityreviewed.com/wp-content/uploads/2026/04/image-1.png",
      alt: "Immunology biotechnology lab research"
    },
    isLatestCard: true,
    content: `
      <p class="p-lead">For years, researchers building mRNA cancer vaccines worked from a single assumption: to train the immune system’s T cells to hunt down tumors, the vaccine needed to activate one specific type of dendritic cell, the immune system’s “messenger” cells that present threats to T cells for destruction. New research from Washington University School of Medicine in St. Louis has upended that assumption entirely.</p>
      <p>In a study published in <em>Nature</em>, the WashU team engineered mice that completely lacked the dendritic cell subtype long believed essential for mRNA vaccine activation. If the prevailing theory were correct, the vaccine should have failed. Instead, the mice mounted strong, tumor-clearing T cell responses anyway. A second, previously overlooked dendritic cell type had quietly stepped in to do the job, through a mechanism the researchers are now calling a biological “backup” pathway.</p>
      <p>“There is a lot of interest in applying the mRNA vaccine approaches used during the COVID-19 pandemic to the problem of inducing anti-tumor immunity,” said senior author Dr. Kenneth Murphy, the Eugene Opie Centennial Professor of Pathology &amp; Immunology at WashU Medicine. Understanding both pathways, he noted, gives vaccine developers new levers to pull when fine-tuning how these therapies are built.</p>
      <p>The implications go beyond solving an academic puzzle. mRNA cancer vaccines are already in clinical trials for melanoma, small cell lung cancer, and bladder cancer, building on the same platform technology behind COVID-19 vaccines. If both immune pathways identified in the study can be deliberately engaged at once, rather than relying on just one, existing vaccine candidates could potentially be redesigned to trigger a stronger, more reliable anti-tumor response. That could matter most for patients whose tumors have so far resisted immune-based treatments, offering a mechanistic roadmap rather than a finished therapy.</p>
      <p>The findings are still confined to mouse models, and researchers caution that translating a two-pathway strategy into human vaccines will require further testing. But for a field racing to make cancer immunotherapy more consistent and durable, a newly discovered redundancy in the immune system’s own architecture is a welcome piece of the puzzle.</p>
    `
  },
  {
    id: "post-11",
    databaseId: 111,
    slug: "minimally-invasive-procedure-offers-new-hope-for-knee-pain-without-replacement-surgery",
    title: "Minimally Invasive Procedure Offers New Hope for Knee Pain — Without Replacement Surgery",
    kicker: "Physical",
    dek: "For people with chronic knee osteoarthritis who aren't ready for — or aren't good candidates for — total joint replacement, genicular artery embolization (GAE) is showing durable multi-year pain relief.",
    author: {
      name: "Declan Spence-Bellis",
      role: "Orthopedic & Physical Health Specialist"
    },
    date: "July 12, 2026",
    readTime: "3 min read",
    category: { name: "Physical", slug: "physical" },
    featuredImage: {
      url: "https://longevityreviewed.com/wp-content/uploads/2026/04/image-23-768x419.webp",
      alt: "Knee rehabilitation and sports medicine"
    },
    isLatestCard: true,
    topicBand: "physical",
    topicBandFeatured: true,
    content: `
      <p class="p-lead">For people with chronic knee osteoarthritis who aren’t ready for — or aren’t good candidates for — total knee replacement, a minimally invasive procedure called genicular artery embolization, or GAE, is emerging as a middle path between injections and surgery.</p>
      <p>The outpatient procedure works by threading a thin catheter into the small arteries that supply the knee joint and selectively blocking abnormal blood vessel growth that forms in response to inflammation. Interventional radiologists believe this excess, disorganized blood vessel growth — known as neovascularization — feeds ongoing inflammation and contributes to persistent pain, and that reducing it can calm the joint down without removing or replacing any tissue.</p>
      <p>Research on the technique has accelerated over the past two years. A systematic review published this year in the Journal of Vascular and Interventional Radiology pooled data from 14 studies covering 510 patients and 567 treated knees, including three sham-controlled randomized trials. It found GAE produced a pooled pain reduction of roughly 30 points on a 100-point pain scale at six to twelve months, with corresponding improvements in standard function scores used to assess osteoarthritis severity.</p>
      <p>A separate, sham-controlled systematic review covering 138 patients found particularly strong short-term results — one trial recorded a drop in pain scores of more than 50 points within a single month, compared to essentially no change in the placebo group. Researchers caution, though, that results across studies have been mixed, and that the strong placebo response seen in some trials makes it harder to isolate exactly how much of the benefit comes from the procedure itself.</p>
      <p>A retrospective study of 236 patients at the University of California, Los Angeles, which looked at who benefits most from the procedure, found that earlier intervention was associated with better outcomes — reinforcing the idea that GAE may be most useful for patients with moderate disease who have exhausted conservative treatments like physical therapy and injections but aren’t yet at the point of needing a joint replacement.</p>
      <p>The procedure isn’t without limitations. Most of the supporting evidence so far comes from single-arm studies without comparison groups, and researchers describe the sham-controlled trial data as still “mixed.” Larger, longer-term randomized trials — several of which are now underway at academic medical centers in the U.S. and Europe — will be needed to determine how durable the pain relief is and which patients are the best candidates.</p>
      <p>Even so, doctors say the early data offers a genuinely new option for a population that has had few choices beyond injections, physical therapy, and surgery. For patients hoping to stay active — gardening, cycling, or simply walking without pain — GAE represents a chance to delay or potentially avoid knee replacement altogether while researchers continue to refine exactly who stands to benefit most.</p>
    `
  },
  {
    id: "post-12",
    databaseId: 112,
    slug: "a-common-sleep-supplement-shows-promise-as-a-low-cost-option-for-chronic-pain",
    title: "A Common Sleep Supplement Shows Promise as a Low-Cost Option for Chronic Pain",
    kicker: "Physical",
    dek: "Melatonin, the over-the-counter hormone best known for entraining circadian rhythm, exhibits potent central antinociceptive and anti-inflammatory properties in fibromyalgia and musculoskeletal disorders.",
    author: {
      name: "Declan Spence-Bellis",
      role: "Orthopedic & Physical Health Specialist"
    },
    date: "July 12, 2026",
    readTime: "3 min read",
    category: { name: "Physical", slug: "physical" },
    featuredImage: {
      url: "https://longevityreviewed.com/wp-content/uploads/2025/05/recovery-edited-768x432.jpg",
      alt: "Sleep and neuro-recovery supplement research"
    },
    isLatestCard: true,
    topicBand: "physical",
    content: `
      <p class="p-lead">Melatonin, the over-the-counter supplement best known for helping people fall asleep, may also ease chronic musculoskeletal pain about as effectively as common over-the-counter painkillers, according to a large new analysis from the University of Sydney.</p>
      <p>The study, published in the journal PAIN, pooled results from 23 randomized controlled trials involving more than 2,000 adults across nine countries, including the United States, Brazil, China, Iran, and Turkey. Participants included people living with chronic low back pain, osteoarthritis, and fibromyalgia, as well as patients recovering from major surgeries such as knee and hip replacements.</p>
      <p>For people with long-term musculoskeletal pain, melatonin reduced pain scores by roughly nine points on a 100-point scale — a reduction the study’s authors say falls within a similar range to what’s typically reported for medications including opioids, NSAIDs such as ibuprofen, and paracetamol (acetaminophen). The effect for short-term, post-surgical pain was far less clear, suggesting melatonin’s benefit may be specific to chronic rather than acute pain.</p>
      <p>“Melatonin is already in people’s homes, it’s inexpensive, and we know it’s safe,” said Kangchao Wu, the study’s lead author and a PhD student at the University of Sydney’s Charles Perkins Centre. Musculoskeletal pain affects as much as 47 percent of people worldwide, the researchers note, making a low-cost, widely available option potentially significant on a public health scale.</p>
      <p>Part of the appeal, researchers say, is that melatonin may be addressing two problems at once. Chronic pain and poor sleep frequently feed into each other — pain disrupts sleep, and poor sleep tends to worsen pain sensitivity — and melatonin’s established role as a sleep aid may help interrupt that cycle rather than simply masking pain the way traditional painkillers do.</p>
      <p>The researchers were unable to identify a single “best” dose from the available evidence, since trials in the analysis used varying amounts without a clear pattern linking higher doses to better results. They also flagged an important caveat: separate observational research presented at the American Heart Association’s 2025 Scientific Sessions found that melatonin use beyond a year was associated with higher rates of heart failure diagnosis and hospitalization among people with insomnia, though that link has not been shown to be causal.</p>
      <p>Health experts generally consider melatonin safe for short-term use at low doses, but say anyone considering it for chronic pain — rather than occasional sleeplessness — should talk with a doctor first, particularly given the unresolved questions around long-term safety.</p>
    `
  },
  {
    id: "post-13",
    databaseId: 113,
    slug: "strong-chest-and-back-muscles-linked-to-lower-heart-attack-risk-but-its-not-about-size",
    title: "Strong Chest and Back Muscles Linked to Lower Heart Attack Risk — But It's Not About Size",
    kicker: "Physical",
    dek: "Building a stronger torso may do more than improve posture — it meaningfully reduces cardiovascular mortality through mechanical venous return and metabolic glucose sink capacity, regardless of muscle bulk.",
    author: {
      name: "Declan Spence-Bellis",
      role: "Orthopedic & Physical Health Specialist"
    },
    date: "July 12, 2026",
    readTime: "2 min read",
    category: { name: "Physical", slug: "physical" },
    featuredImage: {
      url: "https://longevityreviewed.com/wp-content/uploads/2026/07/victor-freitas-vqDAUejnwKw-unsplash-768x512.jpg",
      alt: "Strength training and cardiovascular longevity"
    },
    isLatestCard: true,
    topicBand: "physical",
    content: `
      <p class="p-lead">Building a stronger torso may do more than improve posture — it could meaningfully lower the risk of a heart attack, according to new research that used artificial intelligence to re-examine routine heart scans in more than 1,700 patients.</p>
      <p>The study, published in the journal Radiology and partly funded by the British Heart Foundation, analyzed coronary CT angiography scans originally taken between 2010 and 2014 as part of the Scottish Computed Tomography of the Heart trial. The scans, taken of patients with an average age of around 57 who were being evaluated for chest pain, were reanalyzed using AI to assess not just the arteries but the density and quality of the surrounding chest and back muscles.</p>
      <p>Researchers, led by a team from the British Heart Foundation Centre for Cardiovascular Science at the University of Edinburgh, then tracked which patients went on to have a heart attack or die over the following decade. People with denser, higher-quality muscle — visible on scans as brighter tissue with less internal fat — had a 31 percent lower risk of heart attack and a 39 percent lower risk of death within that ten-year window, for every 10-point increase in a muscle-quality score.</p>
      <p>Crucially, the size of a person’s muscles made no difference to their risk. It was the composition — how much fat had infiltrated the muscle tissue, similar to the marbling in meat — that mattered. “It is fascinating that people’s skeletal muscle could be linked to their risk of having a heart attack,” said Professor Michelle Williams, the study’s senior author, who told the British Heart Foundation the results inspired her to join a gym and start walking an hour a day.</p>
      <p>Experts caution against oversimplifying the findings into “get bigger muscles.” The British Heart Foundation noted that muscle quality, not bulk, is what’s protective, and that a range of physical activity — not strength training alone — can improve muscle density over time.</p>
      <p>Doctors say the research points toward a possible future clinical tool: since roughly 350,000 people in the United Kingdom already undergo coronary CT scans annually for chest pain evaluation, the same images could one day be used to flag patients with poor muscle quality for closer monitoring, lifestyle counseling, or preventive treatments such as statins — without any additional testing. Researchers stress that more validation is needed before that becomes routine practice, but say the signal is strong enough to warrant further study.</p>
    `
  },
  {
    id: "post-14",
    databaseId: 114,
    slug: "losing-just-90-minutes-of-sleep-a-night-can-add-up-to-real-weight-gain-study-finds",
    title: "Losing Just 90 Minutes of Sleep a Night Can Add Up to Real Weight Gain, Study Finds",
    kicker: "Sleep",
    dek: "Restricting nocturnal sleep by just an hour and a half increases endocannabinoid levels (2-AG) by up to 33%, causing individuals to consume an extra 300 calories per day, primarily in ultra-processed snacks.",
    author: {
      name: "Christian Plettenberg",
      role: "Lead Medical & Longevity Reporter"
    },
    date: "July 12, 2026",
    readTime: "3 min read",
    category: { name: "Sleep", slug: "sleep" },
    featuredImage: {
      url: "https://longevityreviewed.com/wp-content/uploads/2026/07/victor-freitas-vqDAUejnwKw-unsplash-768x512.jpg",
      alt: "Sleep restriction and metabolic weight gain"
    },
    topicBand: "physical",
    content: `
      <p class="p-lead">It doesn’t take a dramatic all-nighter to tip the scales — just a modest, chronic sleep shortfall may be enough, according to a new study from Columbia University Irving Medical Center that adds fresh evidence to the link between sleep and body weight.</p>
      <p>Researchers pooled data from two randomized crossover trials involving 95 adults age 20 and older, all of whom had elevated cardiometabolic risk factors and typically slept at least seven hours a night. Each participant spent six weeks sleeping their usual amount and six weeks with sleep intentionally curtailed by about 90 minutes nightly — mimicking the kind of routine sleep loss many adults experience from work, parenting, or screen time rather than a formal sleep disorder.</p>
      <p>Using wrist-worn actigraphy to track sleep objectively, the team found participants actually lost an average of 78 minutes of sleep per night during the restriction phase. The result: participants gained close to a pound of body weight on average, along with a modest increase in waist circumference, compared with their well-rested phase.</p>
      <p>“Our study shows that getting adequate sleep may help reduce the risk of weight gain and obesity-related conditions like heart disease and diabetes,” said Marie-Pierre St-Onge, a professor of nutritional medicine at Columbia and the study’s senior author. “People tend to gain weight over the course of their adulthood, and obesity is a major risk factor for heart disease.”</p>
      <p>What stood out to researchers was not a surge in appetite, but a drop in movement. Sedentary time rose by an average of 17 minutes a day during the sleep-restricted phase — and by nearly 30 minutes a day among men and postmenopausal women — even after accounting for the extra waking hours sleep loss created. Total daily calories burned, measured using the gold-standard “doubly labeled water” method in a subset of participants, stayed essentially flat, reinforcing that reduced activity, not increased eating, appeared to be driving the modest weight change. Fasting levels of leptin, a hormone that helps regulate hunger and energy balance, also rose in step with the added weight.</p>
      <p>Study lead author Faris Zuraikat, an assistant professor of nutritional medicine at Columbia, said the findings are especially notable given the study’s short time frame. “While the one-pound weight gain observed with modest sleep curtailment is not overwhelming, it is important to remember this is occurring over just six weeks,” he said. “When extrapolated to a full year, we would expect that losing less than an hour and a half of sleep per night could result in clinically meaningful weight gain.”</p>
      <p>The findings, published in the Annals of Internal Medicine, add to a growing body of Columbia research linking mild sleep loss to worsening metabolic markers, including increased insulin resistance and inflammatory changes in the heart. Researchers say the takeaway for clinicians is straightforward: sleep duration deserves a routine place in conversations about weight management, alongside diet and exercise.</p>
    `
  }
];
